(CLDX) Celldex Therapeutics - Performance -38% in 12m
CLDX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
3.32%
#32 in Peer-Group
Rel. Strength
13.08%
#6671 in Stock-Universe
Total Return 12m
-38.03%
#115 in Peer-Group
Total Return 5y
74.46%
#16 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 44.56 USD |
| 52 Week Low | 15.13 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 89.03 |
| Buy/Sell Signal +-5 | -0.06 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: CLDX (-38%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: CLDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for CLDX
| Total Return (including Dividends) | CLDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 11.85% | 3.36% | 5.25% |
| 3 Months | 39.42% | 15.73% | 24.13% |
| 12 Months | -38.03% | -7.02% | 14.15% |
| 5 Years | 74.46% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | CLDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 45.7% | 4.4% | 81% |
| 3 Months | 71.6% | 78.8% | 96.9% |
| 12 Months | -91.4% | -85.8% | 44.9% |
| 5 Years | 12.6% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.50 | 8.21% | 6.27% |
| 3 Month | %th71.00 | 20.47% | 12.32% |
| 12 Month | %th43.00 | -33.35% | -45.71% |
| 5 Years | %th93.00 | 130.20% | -17.64% |
FAQs
Does Celldex Therapeutics (CLDX) outperform the market?
No,
over the last 12 months CLDX made -38.03%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months CLDX made 39.42%, while XBI made 15.73%.
Performance Comparison CLDX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
CLDX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 6.7% | 6.6% | -22.9% | -52% |
| US NASDAQ 100 | QQQ | 7% | 6.5% | -23.6% | -51% |
| German DAX 40 | DAX | 8.9% | 13.3% | -35.1% | -67% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 6.9% | 8.6% | -26.3% | -58% |
| Hongkong Hang Seng | HSI | 7.1% | 5.8% | -42.4% | -77% |
| India NIFTY 50 | INDA | 8.6% | 8.4% | -23.2% | -37% |
| Brasil Bovespa | EWZ | 4.3% | 3% | -48% | -48% |
CLDX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 8.1% | 5.9% | -27% | -63% |
| Consumer Discretionary | XLY | 7.2% | 8.7% | -15.3% | -56% |
| Consumer Staples | XLP | 6.4% | 11.2% | -24.6% | -47% |
| Energy | XLE | 6.4% | 4.8% | -18.8% | -38% |
| Financial | XLF | 6% | 6.8% | -27.8% | -68% |
| Health Care | XLV | 7.3% | 9.7% | -15.5% | -33% |
| Industrial | XLI | 6.6% | 7.6% | -30.8% | -63% |
| Materials | XLB | 4.5% | 7.6% | -27.4% | -44% |
| Real Estate | XLRE | 6.8% | 10.9% | -22.6% | -51% |
| Technology | XLK | 6% | 3.2% | -25.2% | -49% |
| Utilities | XLU | 7.8% | 10.1% | -26.1% | -61% |
| Aerospace & Defense | XAR | 8.9% | 4.8% | -41.5% | -87% |
| Biotech | XBI | 5.7% | 8.5% | -9.7% | -31% |
| Homebuilder | XHB | 4.2% | 4.8% | -15.7% | -44% |
| Retail | XRT | 4.2% | 6.9% | -18.6% | -49% |
CLDX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 5.8% | 3.41% | -14.5% | -31% |
| Natural Gas | UNG | 16.2% | 21.7% | -6.1% | -36% |
| Gold | GLD | 6.5% | 13.1% | -43.5% | -77% |
| Silver | SLV | 5.7% | 4.9% | -40.3% | -56% |
| Copper | CPER | 7.7% | 7.3% | -40% | -49% |
CLDX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 8.5% | 10.8% | -19.5% | -36% |
| iShares High Yield Corp. Bond | HYG | 7.9% | 10.3% | -21.8% | -48% |